SCHEMBL805593

SCHEMBL805593

Cc1cc(-c2ccccc2C)nc(-c2ccccc2C(F)(F)F)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 7/20 0.47
SDHB P21912 1/20 0.47
TRPA1 O75762 2/20 0.46
CYP1A2 P05177 5/20 0.45
CYP2D6 P10635 2/20 0.45
CYP2C19 P33261 2/20 0.45
CYP2C9 P11712 1/20 0.45
CLK4 Q9HAZ1 1/20 0.45
RECQL P46063 1/20 0.45
TRPM8 Q7Z2W7 1/20 0.45
TRPV1 Q8NER1 1/20 0.45
HSD11B1 P28845 1/20 0.44
ACP1 P24666 1/20 0.44
CYP3A4 P08684 3/20 0.43
TSHR P16473 2/20 0.43
ALDH1A1 P00352 2/20 0.43
ALOX15 P16050 1/20 0.43
MAPK1 P28482 1/20 0.43
HIF1A Q16665 1/20 0.43
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL805589 0.87 HSD11B1 (0.51) CRHR1TRPA1CYP1A2CYP2D6CYP2C19
SCHEMBL805587 0.85 HSD11B1 (0.49) CRHR1TRPA1CYP1A2CYP2D6CYP2C19
SCHEMBL786243 0.80 KMT2A (0.60) TRPA1CYP1A2CYP2D6CYP2C19CYP2C9
SCHEMBL14393909 0.77 CYP1A2 (0.43) CRHR1TRPA1CYP1A2CYP2D6CYP2C19
SCHEMBL805588 0.76 USP1 (0.46) CRHR1TRPA1CYP1A2CYP2D6CYP2C19
SCHEMBL14164025 0.74 CYP1A2 (0.41) SDHBTRPA1CYP1A2CYP2D6CYP2C19
SCHEMBL5541462 0.74 HSD11B1 (0.55) TRPA1CYP2D6CYP2C19TRPM8TRPV1
SCHEMBL20782565 0.74 HSD11B1 (0.51) CRHR1TRPA1CYP1A2TRPM8TRPV1
SCHEMBL805590 0.74 HSD11B1 (0.51) TRPA1CYP1A2CYP2D6CYP2C19CYP2C9
SCHEMBL2408078 0.73 CYP1A2 (0.66) CYP1A2CYP2D6CYP2C19CYP2C9CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120071657-A1 TRIAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071657-A1 TRIAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS GSK3B, GSK3A, CDK19 CRHR1 1985/4885SDHB 4790/4885TRPA1 4786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.